The diagnostic utility of immunochromatographic (Leptotek) and enzyme-linked immunosorbent assay (ELISA; Panbio) tests for the detection of Leptospira immunoglobulin M antibodies was assessed in febrile adults admitted in Vientiane, Laos. Both tests demonstrated poor diagnostic accuracy using admission serum (Leptotek sensitivity of 47.3% and specificity of 75.5%: ELISA sensitivity of 60.9% and specificity of 65.6%) compared to the Leptospira "gold standard" microscopic agglutination test.
The laboratory diagnosis of acute Leptospira infection is usually dependent on serological methods. The "gold standard" microscopic agglutination test (MAT) requires paired specimens and considerable technical resources and training and is therefore not useful for acute patient management (5) . Rapid methods, such as lateral flow immunochromatographic tests (ICT) and enzyme-linked immunosorbent assay (ELISA) formats that detect leptospiral immunoglobulin M (IgM) antibodies have demonstrated high diagnostic accuracy (1, 4, 8, 10, 11) . However, a recent study in Viet Nam suggested a poor diagnostic utility of such tests there (9) . Here we report the diagnostic accuracy of a commercial ELISA and an ICT for the detection of Leptospira IgM antibodies among adults with fever in the Lao People's Democratic Republic (Laos), where leptospirosis is endemic.
Human sera were collected after informed oral consent was obtained as part of a study to determine the causes of unexplained fever for patients presenting at Mahosot Hospital, Vientiane, Laos, between November 2001 and October 2003 (7) . Paired admission and convalescent-phase serum specimens were available from 186 patients (total sample, n ϭ 372) and stored at Ϫ85°C until tested. Unpaired sera were not included. Ethical approval was granted by the Ethical Review Committee of the Faculty of Medical Sciences, National University of Laos, Vientiane, Laos.
A commercial ELISA (Panbio Pty, Ltd., Australia) for the detection of IgM antibodies against Leptospira species was performed according to the manufacturer's instructions. The results were calculated as "Panbio units" with results of Յ9.0, 9.0 to 11.0, and Ն11.0 defined as negative, equivocal, and positive, respectively. Samples that initially returned an equivocal result were retested. An ICT (Leptotek; Organon-Teknika, The Netherlands) for the detection of Leptospira IgM antibodies was performed according to the manufacturer's instructions. All results were read by eye by the same operator and recorded as positive, equivocal, or negative for the presence of specific IgM antibody. The MAT for Leptospira antibodies was performed by reference laboratories in The Netherlands and Australia. Samples 1 to 36 were assessed at WHO/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis, KIT Biomedical Research, Amsterdam, The Netherlands (2) . Samples 37 to 186 were assessed at the WHO/ FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis in Australia. A patient was considered to have a current or recent Leptospira infection if a serum showed a titer of Ն1:400 or if paired sera demonstrated a fourfold rise over two specimens.
The diagnostic accuracy was calculated for ICT and ELISA by comparing results with the acute-and convalescent-phase MAT results for each patient as an individual case diagnosis. Only admission samples were tested by the ICT. For both ICT and ELISA, equivocal results were regarded as negative. Standard diagnostic accuracy indices of sensitivity, specificity, negative predictive values (NPVs) and positive predictive values (PPVs) with exact 95% confidence intervals (CI), positive and negative likelihood ratios, interquartile (IQR) ranges of days of fever and area under the receiver-operator characteristic curves (AUROCC) were calculated by using Stata/SE 8.0 (Stata Corp., College Station, Texas).
The percentage of patients with a true leptospirosis infection (as defined by MAT diagnostic criteria) was 12.4% (23 of 186). Of these, 78.2% (18 of 23) and 100% had admission and convalescent-phase sample titers of Ն1:400, respectively. The five patients with titers of Ͻ1:400 on admission demonstrated a Ն4-fold rise in titer in the convalescent-phase sample. On admission, patients had been ill for a median of 9 days (IQR 7 to 13), and the median interval between admission and convalescent-phase serum collection was 4.5 days (IQR 2 to 8). The diagnostic sensitivity of both assays was poor (Table 1) . Overall, the sensitivity of the ELISA was 63.0%, with only a marginal increase in sensitivity when using convalescent-phase sera (65.2%) in comparison to admission sera (60.9%). The sensitivity of the ICT (47.8%) was lower than that of the ELISA.
The specificities of the ELISA (55.5%) and ICT (75.5%) were also low, with a lower specificity for convalescent-phase sera than for the admission sera. In comparison to serum from all patients, samples from patients with only 1 to 7 days of fever had higher sensitivity (70.0%) and specificity (70 to 75%) in both assays but with very wide CIs (Table 1) . AUROCC analysis of ELISA accuracy (using the cutoff of Ն11.0 Panbio units as suggested by the manufacturer) versus MAT results gave AUROCC values for admission and convalescent-phase samples of 0.72 (95% CI ϭ 0.59 to 0.84) and 0.67 (95% CI ϭ 0.53 to 0.80) (Fig. 1) , respectively, suggesting that the ELISA was diagnostically uninformative in both sample timing groups. Modeling of positivity cutoff val- (Table 2) failed to find a compromise between sensitivity and specificity that provided sufficient accuracy for diagnostic utility. However, increasing the cutoff to Ն17.0 Panbio units made the assay at least as accurate as the ICT. These data suggest that both assays have poor diagnostic accuracy on early serum specimens in Laos, making them unsuitable for the diagnosis of local acute leptospirosis. Similar poor performance of rapid assays has been reported in the adjacent region of Viet Nam where Leptospira is endemic and where a high proportion of clinically well individuals gave positive IgM results (9) . The Viet Nam study differed from that presented here since the reference comparator was an in-house ELISA rather than the gold standard MAT. The persistence of leptospire IgM antibody for many months after recovery from leptospirosis (3, 6) and repeated exposure to nonpathogenic Leptospira during farming (9) may be significant factors in the poor specificities of the tests. The ICT and ELISA tests assessed in the present study are not sufficiently accurate for the diagnosis of acute leptospirosis infections in Laos. Antigen-based rapid tests or PCR may prove to be more accurate alternatives.
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